Management of iron overload in β-thalassemia patients:: Safety and efficacy of subcutaneous bolus injection of desferrioxamine and bloodletting

被引：0
|
作者：
Bradai, M. [1 ]
Lamraoui, F. [1 ]
Abad, M. T. [1 ]
机构：
[1] Inst Med, Blida, Algeria
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2007年 / 92卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1147
引用
收藏
页码：422 / 422
页数：1
相关论文
共 50 条
  • [31] Efficacy of Combined Desferrioxamine and Deferiprone versus Single Desferrioxamine Therapy in Patients with Major Thalassemia
    Zareifar, Soheila
    Jabbari, Abdolhamid
    Cohan, Nader
    Haghpanah, Sezaneh
    ARCHIVES OF IRANIAN MEDICINE, 2009, 12 (05) : 488 - 491
  • [32] A Cost-Utility Analysis of Deferiprone Compared to Desferrioxamine and Deferasirox for the Treatment of Chronic Myocardial Iron Overload in Thalassemia Patients
    Pepe, Alessia
    Hanif, Aishah
    Bentley, Anthony
    Walker, Roderick
    Frizziero, Ludovica
    Putti, Maria Caterina
    Spasiano, Anna
    Borgna-Pignatti, Caterina
    Maggio, Aurelio
    Neri, Maria Giovanna
    Meloni, Antonella
    BLOOD, 2015, 126 (23)
  • [33] Role of vitamin C as an adjuvant therapy to different iron chelators in young -thalassemia major patients: efficacy and safety in relation to tissue iron overload
    Elalfy, Mohsen S.
    Saber, Maha M.
    Adly, Amira Abdel Moneam
    Ismail, Eman A.
    Tarif, Mohamed
    Ibrahim, Fatma
    Elalfy, Omar M.
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2016, 96 (03) : 318 - 326
  • [34] Role of Vitamin C As an Adjuvant Therapy with Different Iron Chelators in Young β-Thalassemia Major Patients: Safety and Efficacy in Relation to Tissue Iron Overload
    Elalfy, Mohsen Saleh
    Saber, Maha
    Adly, Amira
    Ismail, Eman
    Tarif, Mohamed
    Ibrahim, Fatma
    Elalfy, Omar
    BLOOD, 2014, 124 (21)
  • [35] Efficacy of deferasirox in reducing and preventing cardiac iron overload in β-thalassemia
    Pennell, Dudley J.
    Porter, John B.
    Cappellini, Maria Domenica
    El-Beshlawy, Amal
    Chan, Lee Lee
    Aydinok, Yesim
    Elalfy, Mohsen Saleh
    Sutcharitchan, Pranee
    Li, Chi-Kong
    Ibrahim, Hishamshah
    Viprakasit, Vip
    Kattamis, Antonis
    Smith, Gillian
    Habr, Dany
    Domokos, Gabor
    Roubert, Bernard
    Taher, Ali
    BLOOD, 2010, 115 (12) : 2364 - 2371
  • [36] Combination of Oral Deferiprone and Subcutaneous Infusion of Desferrioxamine in Chelating Overloaded Iron in Pediatric Patients with Beta-Thalassemia Disease
    Chuansumrit, Ampaiwan
    Sirachainan, Norignuch
    Wanichkul, Suthep
    Songdej, Duantida
    Wongwerawattanakoon, Pakawan
    Kadegasem, Praguywan
    BLOOD, 2009, 114 (22) : 1556 - 1556
  • [37] Long-term efficacy of oral deferiprone in management of iron overload in beta thalassemia major
    Goel, Himanshu
    Girisha, K. M.
    Phadke, Shubha R.
    HEMATOLOGY, 2008, 13 (02) : 77 - 82
  • [38] Analysis of efficacy and safety of two iron chelators in patients with iron overload (QueLaFer study)
    Medrano Engay, B.
    Irun, M. P.
    Sarria, L.
    Andrade, M.
    Murillo, I.
    Montes, A.
    Pocovi, M.
    Giraldo, P.
    LEUKEMIA RESEARCH, 2013, 37 : S105 - S105
  • [39] IRON ELIMINATION FOLLOWING INTRAVENOUS DESFERRIOXAMINE INFUSION IN PATIENTS WITH THALASSEMIA MAJOR
    DEVIRGILIIS, S
    FRAU, F
    SANNA, G
    CORNACCHIA, G
    TURCO, MP
    ARGIOLU, F
    CAO, A
    EUROPEAN PAEDIATRIC HAEMATOLOGY AND ONCOLOGY, 1985, 2 (01): : 47 - 48
  • [40] Efficacy and safety of subcutaneous injection of Nuflor® in cattle
    Goossens, L
    TIERARZTLICHE UMSCHAU, 2000, 55 (10): : 563 - 565
12345